(α-β-D-arabinofuranosyladenine; vidarabine). CAS 24356-66-9. A biologically active pharmaceutical product having both antitumor and antiviral properties. It was originally prepared (1959) by chemical synthesis at Stanford Research Institute, and later isolated from a fermentation beer of Streptomyces antibioticus.